FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13162401000001106: Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 02-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    109600401000001118 Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    109600501000001119 Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Is a Product containing fluticasone and salmeterol false Inferred relationship Existential restriction modifier
    Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Has active ingredient Salmeterol false Inferred relationship Existential restriction modifier
    Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Has active ingredient Fluticasone false Inferred relationship Existential restriction modifier
    Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Has dispensed dose form Conventional release powder for inhalation false Inferred relationship Existential restriction modifier
    Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Has specific active ingredient Fluticasone propionate false Inferred relationship Existential restriction modifier
    Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Has specific active ingredient Salmeterol xinafoate false Inferred relationship Existential restriction modifier
    Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol false Inferred relationship Existential restriction modifier
    Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Fluticasone 100micrograms/actuation / Salmeterol 50micrograms/actuation dry powder inhaler 60 dose Has VMP False Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier
    Seretide 100 Accuhaler (Necessity Supplies Ltd) Is a False Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier
    Seretide 100 Accuhaler (Mawdsley-Brooks & Company Ltd) Is a False Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier
    Seretide 100 Accuhaler (Stephar (U.K.) Ltd) Is a False Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier
    Seretide 100 Accuhaler (Lexon (UK) Ltd) Is a False Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier
    Seretide 100 Accuhaler (Sigma Pharmaceuticals Plc) Is a False Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier
    Seretide 100 Accuhaler (Doncaster Pharmaceuticals Ltd) Is a False Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier
    Seretide 100 Accuhaler (PI) (Dowelhurst Ltd) Is a False Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier
    Seretide 100 Accuhaler (PI) (Waymade Ltd) Is a False Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier
    Seretide 100 Accuhaler (GlaxoSmithKline) Is a False Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start